News

A global study of asthma patients has discovered that a combination of two drugs (albuterol–budesonide) reduces the chances of suffering an asthma attack.

A new treatment for cataracts has demonstrated positive results in laboratory tests. The condition, which can only be cured with surgery currently, could soon be treated with drugs.

Researchers have captured the first three-dimensional images that reveal how drug compounds work to stop Plasmodium parasites from spreading in the blood.

The profound health and economic impact of the Pfizer/BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.

Last year, scientists studied the blood of 14 COVID-19 survivors to find the most potent antibodies against the SARS-CoV-2 virus. One of the leading molecules, an antibody dubbed J08, is now in clinical trials in Italy. Now, the same group has visualized exactly how J08 binds to different SARS-CoV-2 variants in different conformations, explaining what makes the monoclonal antibody so potent.

A study has associated the sentiments toward the COVID-19 vaccine presented on Twitter with changes in subsequent vaccination rates.

A drug has been trialed in marginal zone lymphoma patients, with results showing the cancer shrunk in 80% of patients, leading to approval by the FDA for treating the condition.

A phase one clinical trial of a new vaccine for three mosquito-borne encephalitis viruses has shown the vaccine to be safe and capable of inducing an antibody response.

Researchers at Johns Hopkins Medicine have designed nanobodies from llama antibodies that could be used to deliver medicines to human muscle cells.

The bark of the Galbulimima belgraveana tree has long been used by indigenous people for both healing and ceremony. A tea brewed from the bark not only induces a dreamlike state but is said to ease pain and fever. To probe these effects, researchers have isolated more than 40 unique chemicals from the tree bark.